Summary
Biocon reported a 9% year-on-year rise in Q1 total income to 4,391 crore rupees for FY27, with biopharma revenue increasing by 17%. The company's EBITDA stood at 902 crore rupees and net profit at 141 crore rupees, driven by new product launches and strengthened manufacturing capabilities.